Related Experiment Video
Updated: May 30, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
The optimal dose fractionation schema for malignant extradural spinal cord compression
D Andrew Loblaw1, Gunita Mitera
1Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada. andrew.loblaw@sunnybrook.ca
The Journal of Supportive Oncology
|August 4, 2011
Summary
Malignant epidural spinal cord compression prognosis scales guide treatment. For poor prognosis patients, single 8 Gy radiation is effective and convenient, while positive prognosis patients benefit from surgery and radiation.
Area of Science:
- Oncology
- Neurosurgery
- Radiation Oncology
Background:
- Malignant epidural spinal cord compression (MESCC) is a serious complication of cancer.
- Accurate prognosis estimation is crucial for balancing treatment efficacy and patient burden.
- Simple prognostic scales can help individualize treatment strategies for MESCC.
Purpose of the Study:
- To review prognostic scales for malignant epidural spinal cord compression.
- To guide individualized treatment decisions based on patient prognosis.
- To optimize therapeutic approaches for MESCC patients.
Main Methods:
- Review of existing literature on prognostic scales for MESCC.
- Analysis of treatment outcomes based on different prognostic categories.
- Comparison of single-fraction versus multi-fraction radiation therapy efficacy.
Main Results:
- Prognosis scales effectively stratify patients with MESCC.
- For patients with a poor prognosis, a single 8 Gy radiation fraction is as effective as multiple fractions and more convenient.
- Surgery and radiation therapy are recommended for patients with a favorable prognosis.
Conclusions:
- Individualized treatment for MESCC is achievable using prognostic scales.
- Single-fraction 8 Gy radiation offers a convenient and effective option for poor-prognosis patients.
- Clinical trials comparing radiation fractionation are recommended for non-surgical candidates.
